Inpatient Financial Burden of Atopic Dermatitis in the United States

Shanthi Narla, Derek Y. Hsu, Jacob P. Thyssen, Jonathan I. Silverberg*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

50 Scopus citations


Little is known about the inpatient burden of atopic dermatitis (AD). We sought to determine the risk factors and financial burden of hospitalizations for AD in the United States. Data were analyzed from the 2002–2012 National Inpatient Sample, including a 20% representative sample of all hospitalizations in the United States. Hospitalization rates for AD or eczema were highest in the northeast during the winter and south during the summer. Geometric mean cost of care (95% confidence interval) was lower for a primary diagnosis of AD or eczema versus no AD or eczema in adults ($3,502 [$3,360–$3,651] vs. $6,849 [$6,775–$6,925]; P = 0.0004) and children ($2,716 [$2,542–$2,903] vs. $4,488 [$4,302–$4,682]; P = 0.0004). However, the high prevalence of hospitalization resulted in total inpatient costs of $8,288,083 per year for adults and $3,333,868 per year for children. In conclusion, there is a substantial inpatient financial burden of AD in the United States.

Original languageEnglish (US)
Pages (from-to)1461-1467
Number of pages7
JournalJournal of Investigative Dermatology
Issue number7
StatePublished - Jul 2017

ASJC Scopus subject areas

  • Dermatology
  • Molecular Biology
  • Biochemistry
  • Cell Biology


Dive into the research topics of 'Inpatient Financial Burden of Atopic Dermatitis in the United States'. Together they form a unique fingerprint.

Cite this